Kolexia
Durr Alexandra
Neurologie
Hôpital Pitie Salpetriere
Paris, France
443 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Ataxie Maladie de Huntington Ataxie cérébelleuse Ataxies spinocérébelleuses Ataxie de Friedreich Spasticité musculaire Paraplégie spasmodique héréditaire Paraplégie Atrophie

Industries

UCB
1 collaboration(s)
Dernière en 2022
REATA SWISS INTERNATIONAL GMBH
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD): A Phase 2A, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of PTC518 in Subjects With Huntington's Disease
Essai Clinique (PTC Therapeutics)   14 mars 2024
UNIFAI: Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
Essai Clinique (Friedreich's Ataxia Research Alliance)   07 mars 2024
ATXN7-Related Cone-Rod Dystrophy: The Integrated Functional Evaluation of the Cerebellum (CERMOI) Study.
JAMA ophthalmology   29 février 2024
Digital Gait Measures Capture 1-Year Progression in Early-Stage Spinocerebellar Ataxia Type 2.
Movement disorders : official journal of the Movement Disorder Society   28 février 2024
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Essai Clinique (CHDI Foundation, Inc.)   26 février 2024
Genotype-specific spinal cord damage in spinocerebellar ataxias: an ENIGMA-Ataxia study.
Journal of neurology, neurosurgery, and psychiatry   21 février 2024
PROFA: Patient-reported, Health Economic and Psychosocial Outcomes in Friedreich Ataxia
Essai Clinique (German Center for Neurodegenerative Diseases (DZNE))   16 février 2024
NICOFA: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicentre Study of the Efficacy and Safety of Nicotinamide in Patients With Friedreich Ataxia
Essai Clinique (RWTH Aachen University)   22 janvier 2024
FGF14 : a frequent new causal expansion in cerebellar ataxias
Abstracts from the 56th European Society of Human Genetics (ESHG) Conference   01 janvier 2024
Whole-Genome Sequencing Analysis Reveals New Susceptibility Loci and Structural Variants Associated with Progressive Supranuclear Palsy.
medRxiv : the preprint server for health sciences   30 décembre 2023